查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2031053

全球止血劑市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

Global Hemostats Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球止血劑市場預計將從2025年的36.9億美元成長至2034年的68.2億美元，2026年至2034年的複合年成長率（CAGR）為7.07%。此市場擴張的主要原因是外科手術和創傷治療中對有效止血解決方案的需求不斷成長。止血劑是用於在手術和緊急情況下止血的醫療設備和藥物。手術數量的增加和對病人安全的日益關注是推動市場成長的重要因素。醫療專業人員正在採用先進的止血產品來改善治療效果並減少併發症。

推動止血劑市場成長的主要因素包括醫療技術的進步、醫療保健成本的上升以及需要手術干預的慢性疾病盛行率的增加。止血劑廣泛應用於醫院、門診手術中心及急診醫療機構。生物相容性和可吸收材料的研發提高了產品的性能。此外，微創手術的普及也支撐了市場需求。

由於止血劑和器械領域的持續創新，市場前景依然強勁。起效更快、更有效率的產品的研發將改善手術效果。隨著醫療基礎設施的改善，新興市場預計將迎來顯著的成長機會。隨著對先進外科解決方案的需求不斷成長，止血劑市場預計將持續擴張。

我們的報告經過精心撰寫，旨在提供涵蓋廣泛行業和市場的全面且切實可行的洞察。每份報告都包含幾個關鍵組成部分，旨在幫助您全面了解市場環境：

市場概覽：本節提供清晰的市場概覽，包括關鍵定義、分類和當前產業格局。

市場動態：對影響市場成長的主要促進因素、限制因素、機會和挑戰進行詳細評估。這包括技術發展、法律規範和不斷變化的行業趨勢等因素。

市場區隔分析：本部分依據產品類型、應用、最終使用者和地區，將市場系統性地分類為若干關鍵細分市場。本部分揭示了每個細分市場的表現、成長潛力和市場貢獻。

競爭格局：我們對主要市場參與企業的市場定位、產品系列、策略舉措和財務表現進行了詳細評估。這為深入了解競爭動態和主要參與者所採取的策略提供了寶貴的見解。

市場預測：本預測是基於特定預測期內的市場規模和成長模式數據。本節結合歷史趨勢、當前市場狀況和定量分析，揭示未來預期趨勢。

區域分析：本部分全面回顧了主要地理區域的市場表現，確定了高成長領域和區域趨勢，從而更深入地了解區域市場機會。

新趨勢與新機會：識別關鍵市場趨勢、技術進步和新興投資機會。本部分重點在於潛在成長領域和未來產業趨勢。

客製化選項：我們提供靈活的客製化服務，可根據您的具體需求自訂報告。這包括額外的細分、特定國家/地區的分析、競爭對手分析、客製化資料點或專注於特定細分市場的洞察，以更好地支持您的策略決策。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章 全球止血劑市場：按類型分類

  • 市場分析、洞察與預測
  • 凝血酶止血劑
  • 氧化再生纖維素止血劑
  • 複方止血劑
  • 其他

第5章 全球止血劑市場：以劑型分類

  • 市場分析、洞察與預測
  • 基質型和凝膠型止血劑
  • 海綿止血劑
  • 粉狀止血劑
  • 其他

第6章 全球止血劑市場：依應用分類

  • 市場分析、洞察與預測
  • 整形外科手術
  • 一般外科
  • 神經外科
  • 心血管外科
  • 其他

第7章：全球止血劑市場：依最終用途分類

  • 市場分析、洞察與預測
  • 醫院和診所
  • 門診手術中心
  • 急診中心
  • 其他

第8章 全球止血劑市場：按地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 亞太其他地區
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲

第9章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第10章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Johnson & Johnson
    • CryoLife, Inc（Artivion）
    • Integra LifeSciences Corporation
    • Pfizer
    • B. Braun Melsungen AG
    • Becton, Dickinson, And Company
    • Medtronic
    • Baxter
    • Stryker Corporation
    • Teleflex Inc
    • Towne Brothers Pvt. Ltd
    • World Precision Instruments
    • Ydm Corp
簡介目錄
Product Code: VMR112117964

The global hemostats market size is expected to reach USD 6.82 Billion in 2034 from USD 3.69 Billion in 2025, growing at a CAGR of 7.07 during 2026-2034.This market is advancing as surgical procedures and trauma care demand effective bleeding control solutions. Hemostats are medical devices and agents used to stop bleeding during surgeries and emergencies. The increasing number of surgical procedures and the growing focus on patient safety are contributing to market growth. Healthcare providers are adopting advanced hemostatic products to improve outcomes and reduce complications.

Key drivers include advancements in medical technology, increasing healthcare expenditure, and the rising prevalence of chronic diseases requiring surgical intervention. Hemostats are widely used in hospitals, ambulatory surgical centers, and emergency care settings. The development of biocompatible and absorbable materials is enhancing product performance. Additionally, the growth of minimally invasive procedures is supporting market demand.

Future prospects remain strong, with continuous innovation in hemostatic agents and devices. The development of faster-acting and more efficient products will improve surgical outcomes. Emerging markets are expected to offer significant growth opportunities due to improving healthcare infrastructure. As demand for advanced surgical solutions increases, the hemostats market is poised for sustained expansion.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Type

  • Thrombin Based Hemostats
  • Oxidized Regenerated Cellulose Based Hemostats
  • Combination Hemostats
  • Others

By Formulation

  • Matrix & Gel Hemostats
  • Sponge Hemostats
  • Powder Hemostats
  • Others

By Application

  • Orthopedic Surgery
  • General Surgery
  • Neurological Surgery
  • Cardiovascular Surgery
  • Others

By End-use

  • Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Casualty Care Centers
  • Others

COMPANIES PROFILED

  • Johnson & Johnson, CryoLife, Inc (Artivion), Integra LifeSciences Corporation, Pfizer, B. Braun Melsungen AG, Becton, Dickinson, and Company, Medtronic, Baxter, Stryker Corporation, Teleflex Inc., Towne Brothers Pvt. Ltd., World Precision Instruments, Ydm Corp.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL HEMOSTATS MARKET: BY TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Type
  • 4.2. Thrombin Based Hemostats Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Oxidized Regenerated Cellulose Based Hemostats Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Combination Hemostats Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL HEMOSTATS MARKET: BY FORMULATION 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Formulation
  • 5.2. Matrix & Gel Hemostats Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Sponge Hemostats Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Powder Hemostats Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL HEMOSTATS MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Application
  • 6.2. Orthopedic Surgery Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. General Surgery Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Neurological Surgery Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.5. Cardiovascular Surgery Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL HEMOSTATS MARKET: BY END-USE 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast End-use
  • 7.2. Hospitals & Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.4. Casualty Care Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL HEMOSTATS MARKET: BY REGION 2022-2034 (USD MN)

  • 8.1. Regional Outlook
  • 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.2.1 By Type
    • 8.2.2 By Formulation
    • 8.2.3 By Application
    • 8.2.4 By End-use
    • 8.2.5 United States
    • 8.2.6 Canada
    • 8.2.7 Mexico
  • 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.3.1 By Type
    • 8.3.2 By Formulation
    • 8.3.3 By Application
    • 8.3.4 By End-use
    • 8.3.5 United Kingdom
    • 8.3.6 France
    • 8.3.7 Germany
    • 8.3.8 Italy
    • 8.3.9 Russia
    • 8.3.10 Rest Of Europe
  • 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.4.1 By Type
    • 8.4.2 By Formulation
    • 8.4.3 By Application
    • 8.4.4 By End-use
    • 8.4.5 India
    • 8.4.6 Japan
    • 8.4.7 South Korea
    • 8.4.8 Australia
    • 8.4.9 South East Asia
    • 8.4.10 Rest Of Asia Pacific
  • 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.5.1 By Type
    • 8.5.2 By Formulation
    • 8.5.3 By Application
    • 8.5.4 By End-use
    • 8.5.5 Brazil
    • 8.5.6 Argentina
    • 8.5.7 Peru
    • 8.5.8 Chile
    • 8.5.9 Rest of Latin America
  • 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.6.1 By Type
    • 8.6.2 By Formulation
    • 8.6.3 By Application
    • 8.6.4 By End-use
    • 8.6.5 Saudi Arabia
    • 8.6.6 UAE
    • 8.6.7 Israel
    • 8.6.8 South Africa
    • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

  • 9.1. Recent Developments
  • 9.2. Company Categorization
  • 9.3. Supply Chain & Channel Partners (based on availability)
  • 9.4. Market Share & Positioning Analysis (based on availability)
  • 9.5. Vendor Landscape (based on availability)
  • 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL HEMOSTATS INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Company Profiles
    • 10.2.1 Johnson & Johnson
    • 10.2.2 CryoLife, Inc (Artivion)
    • 10.2.3 Integra LifeSciences Corporation
    • 10.2.4 Pfizer
    • 10.2.5 B. Braun Melsungen AG
    • 10.2.6 Becton, Dickinson, And Company
    • 10.2.7 Medtronic
    • 10.2.8 Baxter
    • 10.2.9 Stryker Corporation
    • 10.2.10 Teleflex Inc
    • 10.2.11 Towne Brothers Pvt. Ltd
    • 10.2.12 World Precision Instruments
    • 10.2.13 Ydm Corp